Physician profile
Kipp M Robins
NPI 1396741476
$1,281.86
in general payments reported to CMS, 2019-2025
9 companies · $15.85 in 2025
The $15.85 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $11.46 · 2021: $15.31 · 2022: $55.48 · 2023: $34.78 · 2024: $45.07 · 2025: $15.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,089.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $45.07 | 2024 | Exparel |
| Merck Sharp & Dohme LLC | $29.83 | 2021-2023 | Bridion |
| Glaxosmithkline, LLC. | $28.82 | 2022-2025 | Nucala |
| Acclarent, INC | $24.30 | 2022 | |
| Boston Scientific Corporation | $20.26 | 2023 | |
| Optinose US, INC. | $18.21 | 2022 | |
| A-Dec, INC. | $14.25 | 2019 | |
| Stryker Corporation | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kipp Robins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.